生产-话题@MedSci

#生产#

189篇内容 | 3796人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1517842, encodeId=8c92151e8427a, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=赛诺菲首席执行官：将生产1亿剂辉瑞BioNTech新冠疫苗, objectType=article, longId=206418, objectId=9df620641827, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9df620641827, replyNumber=0, likeNumber=47, createdTime=2021-01-31, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9df620641827, moduleTitle=赛诺菲首席执行官：将生产1亿剂辉瑞BioNTech新冠疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9df620641827)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517841, encodeId=ab21151e841ea, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=ARTMS和Isotopia Molecular Imaging宣布成功通过QUANTM Irradiation System™和固态靶材，用经由回旋加速器生产的68Ga对PSMA-11进行多居里标记, objectType=article, longId=206000, objectId=9bbf2060009c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bbf2060009c, replyNumber=0, likeNumber=77, createdTime=2021-01-23, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bbf2060009c, moduleTitle=ARTMS和Isotopia Molecular Imaging宣布成功通过QUANTM Irradiation System™和固态靶材，用经由回旋加速器生产的68Ga对PSMA-11进行多居里标记, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bbf2060009c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517840, encodeId=d976151e8403e, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒, objectType=article, longId=205740, objectId=214b205e4021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=214b205e4021, replyNumber=0, likeNumber=55, createdTime=2021-01-16, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=214b205e4021, moduleTitle=ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=214b205e4021)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517839, encodeId=2fd6151e8394a, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=JAMA Netw Open：试管婴儿患癌风险比自然生产增加200%！出生缺陷比例也更高, objectType=article, longId=202950, objectId=a9692029509c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9692029509c, replyNumber=0, likeNumber=59, createdTime=2020-11-07, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9692029509c, moduleTitle=JAMA Netw Open：试管婴儿患癌风险比自然生产增加200%！出生缺陷比例也更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9692029509c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517838, encodeId=28e6151e8380d, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=药监局：2026年起全面禁止生产含汞体温计和含汞血压计产品, objectType=article, longId=202819, objectId=bef720281975, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bef720281975, replyNumber=0, likeNumber=56, createdTime=2020-11-04, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bef720281975, moduleTitle=药监局：2026年起全面禁止生产含汞体温计和含汞血压计产品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bef720281975)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517837, encodeId=9ae5151e83744, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=原料药行业迎重磅利好！工信部：推动建设原料药集中生产基地, objectType=article, longId=201553, objectId=32e720155361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32e720155361, replyNumber=0, likeNumber=60, createdTime=2020-10-04, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32e720155361, moduleTitle=原料药行业迎重磅利好！工信部：推动建设原料药集中生产基地, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32e720155361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517836, encodeId=a15a151e83685, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=药监局发布进口医疗器械产品在中国境内企业生产相关公告, objectType=article, longId=201546, objectId=668c20154682, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=668c20154682, replyNumber=0, likeNumber=82, createdTime=2020-10-04, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=668c20154682, moduleTitle=药监局发布进口医疗器械产品在中国境内企业生产相关公告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=668c20154682)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517835, encodeId=d323151e83533, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=吉利德宣布将以210亿美元收购癌症药物生产商Immunomedics, objectType=article, longId=200661, objectId=f19a2006611d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f19a2006611d, replyNumber=0, likeNumber=68, createdTime=2020-09-15, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f19a2006611d, moduleTitle=吉利德宣布将以210亿美元收购癌症药物生产商Immunomedics, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f19a2006611d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517834, encodeId=5378151e834fe, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=非常时期埋头研发——一家医疗器械生产企业的突围之路, objectType=article, longId=200654, objectId=c60e200654aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c60e200654aa, replyNumber=0, likeNumber=74, createdTime=2020-09-15, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c60e200654aa, moduleTitle=非常时期埋头研发——一家医疗器械生产企业的突围之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c60e200654aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517833, encodeId=7d86151e833a6, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=海关总署：对检出新冠病毒的进口冷链食品境外生产商实施紧急预防性措施, objectType=article, longId=200582, objectId=69d8200582fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69d8200582fa, replyNumber=0, likeNumber=62, createdTime=2020-09-13, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69d8200582fa, moduleTitle=海关总署：对检出新冠病毒的进口冷链食品境外生产商实施紧急预防性措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69d8200582fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517832, encodeId=b801151e83210, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=中国昆虫细胞生产的重组蛋白新冠疫苗获得国家临床试验许可, objectType=article, longId=199870, objectId=ada21998e00a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ada21998e00a, replyNumber=0, likeNumber=66, createdTime=2020-08-25, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ada21998e00a, moduleTitle=中国昆虫细胞生产的重组蛋白新冠疫苗获得国家临床试验许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ada21998e00a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517831, encodeId=6773151e83176, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=辉瑞公司将生产瑞德昔韦，增加产能, objectType=article, longId=199064, objectId=9657199064f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9657199064f3, replyNumber=0, likeNumber=60, createdTime=2020-08-11, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9657199064f3, moduleTitle=辉瑞公司将生产瑞德昔韦，增加产能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9657199064f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517830, encodeId=a171151e83084, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=印度血清研究所（SII）将生产阿斯利康和Novavax的COVID-19疫苗, objectType=article, longId=199061, objectId=afff1990615d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afff1990615d, replyNumber=0, likeNumber=62, createdTime=2020-08-11, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afff1990615d, moduleTitle=印度血清研究所（SII）将生产阿斯利康和Novavax的COVID-19疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afff1990615d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517829, encodeId=c67d151e8298a, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=英国正在提高COVID-19疫苗的生产能力, objectType=article, longId=198726, objectId=3df5198e26fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3df5198e26fc, replyNumber=0, likeNumber=67, createdTime=2020-08-06, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3df5198e26fc, moduleTitle=英国正在提高COVID-19疫苗的生产能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3df5198e26fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517828, encodeId=7e6b151e828d3, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=CDMO或可加速COVID-19候选疫苗的大规模生产, objectType=article, longId=198198, objectId=d29019819849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d29019819849, replyNumber=0, likeNumber=63, createdTime=2020-07-30, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d29019819849, moduleTitle=CDMO或可加速COVID-19候选疫苗的大规模生产, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d29019819849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517827, encodeId=33f8151e8275d, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=World Allergy Organ J：孕妇生产年龄与学龄儿童过敏性鼻炎相关性分析 , objectType=article, longId=197730, objectId=986b19e730a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=986b19e730a6, replyNumber=0, likeNumber=64, createdTime=2020-07-20, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=986b19e730a6, moduleTitle=World Allergy Organ J：孕妇生产年龄与学龄儿童过敏性鼻炎相关性分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=986b19e730a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517826, encodeId=08e0151e826de, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=成也资本，败也资本，企业医院“二次改制”破局生产关系, objectType=article, longId=197532, objectId=1c1319e5325e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c1319e5325e, replyNumber=0, likeNumber=69, createdTime=2020-07-16, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c1319e5325e, moduleTitle=成也资本，败也资本，企业医院“二次改制”破局生产关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c1319e5325e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517825, encodeId=4a6f151e825c4, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=这些中药饮片，禁止生产销售, objectType=article, longId=196271, objectId=3a0d1962e11f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a0d1962e11f, replyNumber=0, likeNumber=88, createdTime=2020-06-24, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a0d1962e11f, moduleTitle=这些中药饮片，禁止生产销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a0d1962e11f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517824, encodeId=0a0c151e8244c, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=价格一降再降！口罩企业“冰火两重天”：有的日产千万，有的暂停生产线…, objectType=article, longId=195452, objectId=be0b19545254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be0b19545254, replyNumber=0, likeNumber=82, createdTime=2020-06-09, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be0b19545254, moduleTitle=价格一降再降！口罩企业“冰火两重天”：有的日产千万，有的暂停生产线…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be0b19545254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1517823, encodeId=c0bf151e8237d, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, objectTitle=赛诺菲持续加码胰岛素生产布局，推动药品和疾病解决方案的创新, objectType=article, longId=194589, objectId=7b8419458981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b8419458981, replyNumber=0, likeNumber=73, createdTime=2020-05-24, rootId=0, userName=ms1343860338762272, userId=37a111112788, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b8419458981, moduleTitle=赛诺菲持续加码胰岛素生产布局，推动药品和疾病解决方案的创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b8419458981)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生产

2020-05-29

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

赛诺菲首席执行官：将生产1亿剂辉瑞BioNTech新冠疫苗

2021-01-31

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

ARTMS和Isotopia Molecular Imaging宣布成功通过QUANTM Irradiation System™和固态靶材，用经由回旋加速器生产的68Ga对PSMA-11进行多居里标记

2021-01-23

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒

2021-01-16

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

JAMA Netw Open：试管婴儿患癌风险比自然生产增加200%！出生缺陷比例也更高

2020-11-07

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

药监局：2026年起全面禁止生产含汞体温计和含汞血压计产品

2020-11-04

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

原料药行业迎重磅利好！工信部：推动建设原料药集中生产基地

2020-10-04

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

药监局发布进口医疗器械产品在中国境内企业生产相关公告

2020-10-04

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

吉利德宣布将以210亿美元收购癌症药物生产商Immunomedics

2020-09-15

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

非常时期埋头研发——一家医疗器械生产企业的突围之路

2020-09-15

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

海关总署：对检出新冠病毒的进口冷链食品境外生产商实施紧急预防性措施

2020-09-13

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

中国昆虫细胞生产的重组蛋白新冠疫苗获得国家临床试验许可

2020-08-25

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

辉瑞公司将生产瑞德昔韦，增加产能

2020-08-11

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

印度血清研究所（SII）将生产阿斯利康和Novavax的COVID-19疫苗

2020-08-11

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

英国正在提高COVID-19疫苗的生产能力

2020-08-06

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

CDMO或可加速COVID-19候选疫苗的大规模生产

2020-07-30

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

World Allergy Organ J：孕妇生产年龄与学龄儿童过敏性鼻炎相关性分析

2020-07-20

一叶知秋 (审核中...)

前往app查看评论内容

#生产#

成也资本，败也资本，企业医院“二次改制”破局生产关系

2020-07-16

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

这些中药饮片，禁止生产销售

2020-06-24

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

价格一降再降！口罩企业“冰火两重天”：有的日产千万，有的暂停生产线…

2020-06-09

ms1343860338762272 (审核中...)

前往app查看评论内容

#生产#

赛诺菲持续加码胰岛素生产布局，推动药品和疾病解决方案的创新

2020-05-24

科室
- - 订阅+
  - 更多科室
工具
服务